Award
National Institute of Neurological Disorders and Stroke 5R01NS129192-04
Safety of Anti-CGRP Migraine Therapeutics in Ischemic Stroke
Recipient
Not specified
Award Amount
$532,299.00
Ceiling
$532,299.00
Awarded
May 19, 2026
Identifier
5R01NS129192-04
NIH-funded research project to study the safety of anti-CGRP migraine therapeutics in ischemic stroke, focusing on stroke risk and using in vivo optical imaging.
Description
This is a NIH-funded research project examining the cerebrovascular safety of anti-CGRP migraine therapeutics, with a focus on stroke risk. The project involves in vivo optical imaging studies and aims to refine the target population for these treatments.